In vivo Overhauser-enhanced MRI of proteolytic activity

Neha Koonjoo1, Elodie Parzy, Philippe Massot

  • 1Centre de Résonance Magnétique des Systèmes Biologiques, UMR 5536 CNRS Université Bordeaux Segalen, Bordeaux, France.

Insights

Overhauser-enhanced MRI (OMRI) visualizes proteolysis in vivo by tracking nitroxide-labeled macromolecules. This technique successfully detected elastase activity in mouse duodenum after oral administration of labeled elastin.

Area of Science:

  • Biomedical Imaging
  • Molecular Imaging
  • Magnetic Resonance Imaging

Background:

  • Developing in vivo imaging strategies for proteolytic activity is crucial.
  • Overhauser-enhanced MRI (OMRI) detects proteolysis by monitoring changes in nitroxide moiety rotational correlation time.
  • Nitroxide-labeled macromolecules show a sharp decrease in rotational correlation time upon cleavage.

Purpose of the Study:

  • To demonstrate in vivo Overhauser-enhanced MRI (OMRI) for sensing proteolytic activity.
  • To illustrate the concept using orally administered nitroxide-labeled elastin in mice.
  • To evaluate the potential of OMRI for disease modeling and drug testing.

Main Methods:

  • In vitro and in vivo Overhauser-enhanced MRI (OMRI) at 0.2 T.
  • Oral administration of nitroxide-labeled elastin in mice.
  • Three-dimensional OMRI acquisition using a keyhole fully balanced steady-state free precession sequence (20 s at 0.125 mm(3) resolution).

Main Results:

  • In vitro, elastin derivative showed high Overhauser enhancements (19-fold) upon proteolysis by pancreatic porcine elastase.
  • In vivo, proteolysis was detected in the duodenum approximately 30 min after oral administration (Overhauser enhancements of 7.2 ± 2.4).
  • No proteolysis was observed in the stomach; free nitroxides or pre-digested elastin were detected in the stomach.

Conclusions:

  • Overhauser-enhanced MRI (OMRI) successfully visualizes in vivo proteolysis.
  • The technique allows for spatial and temporal detection of enzymatic activity in specific organs.
  • OMRI holds promise for evaluating proteolytic activities in disease models and for drug screening.